CN101342360B - Chinese medicinal composition for treating esophagus cancer - Google Patents
Chinese medicinal composition for treating esophagus cancer Download PDFInfo
- Publication number
- CN101342360B CN101342360B CN2008101388894A CN200810138889A CN101342360B CN 101342360 B CN101342360 B CN 101342360B CN 2008101388894 A CN2008101388894 A CN 2008101388894A CN 200810138889 A CN200810138889 A CN 200810138889A CN 101342360 B CN101342360 B CN 101342360B
- Authority
- CN
- China
- Prior art keywords
- herba
- chinese medicine
- treatment
- rhizoma
- herb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 21
- 208000000461 Esophageal Neoplasms Diseases 0.000 title abstract description 3
- 201000004101 esophageal cancer Diseases 0.000 title abstract description 3
- 239000003814 drug Substances 0.000 claims abstract description 60
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims abstract description 24
- 241000489492 Arisaema Species 0.000 claims abstract description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 210000000941 bile Anatomy 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 208000017897 Carcinoma of esophagus Diseases 0.000 claims description 22
- 201000005619 esophageal carcinoma Diseases 0.000 claims description 22
- 241001312741 Gekko swinhonis Species 0.000 claims description 19
- 241000208340 Araliaceae Species 0.000 claims description 13
- 241000269417 Bufo Species 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 abstract description 17
- 238000002360 preparation method Methods 0.000 abstract description 11
- 239000000706 filtrate Substances 0.000 abstract description 10
- 206010028980 Neoplasm Diseases 0.000 abstract description 8
- 210000003238 esophagus Anatomy 0.000 abstract description 7
- 201000011510 cancer Diseases 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 210000001835 viscera Anatomy 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 5
- 241000208365 Celastraceae Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241000132446 Inula Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 244000084767 Potentilla indica Species 0.000 abstract 1
- 241000915604 Scutellaria barbata Species 0.000 abstract 1
- 244000261559 Smilax china Species 0.000 abstract 1
- 235000000485 Smilax china Nutrition 0.000 abstract 1
- 240000009022 Smilax rotundifolia Species 0.000 abstract 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 1
- 235000000336 Solanum dulcamara Nutrition 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 230000035622 drinking Effects 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 abstract 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 14
- 235000013305 food Nutrition 0.000 description 9
- 206010047700 Vomiting Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000005202 decontamination Methods 0.000 description 4
- 230000003588 decontaminative effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 208000019505 Deglutition disease Diseases 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000037114 Symptom Flare Up Diseases 0.000 description 1
- 241000616933 Trichiurus haumela Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Chinese medicine combination for curing esophageal cancer and a preparation method thereof. The Chinese medicine combination contains the following weight proportion of traditional Chinese medicinal herb materials: 19g of bittersweet herb, 10g of Indian mockstrawberry herb, 7g of Indian buead, 10g of tangerine peel, 10g of inula flower, 10g of barbed skullcap herb, 20g of spreading hedyotis herb, 3g of chinaroot greenbrier rhizome, 4g of gecko, 20g of Chinese date, 20g of rhizoma zingiberis recens, 10g of arisaema cum bile, 10g of red ochre, 3g of toad, 10g of ginseng and 10g of pinellia tuber. In the preparation method, the impurities of medicinal materials are removed, the gecko is first baked and pulverized for later use, all the medicinal materials are then immersed into water and decocted, liquor is filtered out to remove dregs, and after two filtrates are combined, the gecko powder is put into the filtrate, which is then uniformly stirred until decoction is prepared. Each of the materials is pulverized into powder of 200 to 500 meshes, and all the medicinal powders are uniformly mixed to prepare a powder preparation. The combination of the traditional Chinese medicinal herb materials, which is aimed at the treatment of both symptom and root cause, can enhance the immunity of the human body and prevent cancer cells from metastasizing to other viscera, so that a tumour finally shrinks and is gradually disappeared, and at the same time, the esophagus become expedite, so that eating and drinking can return to normal.
Description
Technical field
The present invention relates to medicine, be a kind of be a kind of Chinese medicine composition for the treatment of esophageal carcinoma and preparation method thereof of raw material with the Chinese herbal medicine.
Background technology
It is reported that because the esophageal carcinoma sickness rate that multiple factors such as diet and environmental pollution cause rises year by year, the treatment means that the patient adopts mainly is an operative treatment.Because the methods such as chemotherapy behind the operative treatment are bigger to the damaging effect of human body, and its survival rate is relatively low, so some patient selects treatment by Chinese herbs for use, to avoid the misery in the operative treatment.The Chinese medicine of having reported the treatment esophageal carcinoma has multiple medicine, but its curative effect has than big difference, and produce effects is slower.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition for the treatment of esophageal carcinoma and preparation method thereof, it adopts the method for the treatment of both the principal and secondary aspects of a disease, and strengthening vital QI to eliminate pathogenic factors reaches the purpose for the treatment of esophageal carcinoma.
The present invention for achieving the above object, be achieved through the following technical solutions: a kind of Chinese medicine composition for the treatment of esophageal carcinoma, form by the raw material of Chinese medicine of following weight ratio: Herba Solani Lyrati 5-25g, Herba Duchesneae Indicae 5-15g, Poria 5-10g, Pericarpium Citri Reticulatae 5-15g, Flos Inulae 5-15g, Herba Scutellariae Barbatae 5-15g, Herba Hedyotidis Diffusae 5-35g, Rhizoma Smilacis Chinensis 1-4.5g, Gekko Swinhonis 3-6g, Fructus Jujubae 5-35g, Rhizoma Zingiberis Recens 5-35g, Arisaema Cum Bile 5-15g, Haematitum 5-15g, Bufo siccus 0.5-5g, Radix Ginseng 5-15g and Rhizoma Pinelliae 5-15g.
A kind of Chinese medicine composition for the treatment of esophageal carcinoma of the present invention, it can be made up of the raw material of Chinese medicine of following weight ratio: Herba Solani Lyrati 25g, Herba Duchesneae Indicae 15g, Poria 10g, Pericarpium Citri Reticulatae 15g, Flos Inulae 15g, Herba Scutellariae Barbatae 15g, Herba Hedyotidis Diffusae 35g, Rhizoma Smilacis Chinensis 4.5g, Gekko Swinhonis 6g, Fructus Jujubae 35g, Rhizoma Zingiberis Recens 35g, Arisaema Cum Bile 15g, Haematitum 15g, Bufo siccus 5g, Radix Ginseng 15g and Rhizoma Pinelliae 15g.
Described a kind of Chinese medicine composition for the treatment of esophageal carcinoma, preferred scheme is to adopt the raw material of Chinese medicine of following weight ratio to form: Herba Solani Lyrati 19g, Herba Duchesneae Indicae 10g, Poria 7g, Pericarpium Citri Reticulatae 10g, Flos Inulae 10g, Herba Scutellariae Barbatae 10g, Herba Hedyotidis Diffusae 20g, Rhizoma Smilacis Chinensis 3g, Gekko Swinhonis 4g, Fructus Jujubae 20g, Rhizoma Zingiberis Recens 20g, Arisaema Cum Bile 10g, Haematitum 10g, Bufo siccus 3g, Radix Ginseng 10g and Rhizoma Pinelliae 10g.
A kind of Chinese medicine composition for the treatment of esophageal carcinoma of the present invention, further preferred scheme is to adopt the raw material of Chinese medicine of following weight ratio to form: Herba Solani Lyrati 16g, Herba Duchesneae Indicae 7g, Poria 6g, Pericarpium Citri Reticulatae 7g, Flos Inulae 7g, Herba Scutellariae Barbatae 7g, Herba Hedyotidis Diffusae 15g, Rhizoma Smilacis Chinensis 2g, Gekko Swinhonis 3g, Fructus Jujubae 15g, Rhizoma Zingiberis Recens 15g, Arisaema Cum Bile 7g, Haematitum 7g, Bufo siccus 2g, Radix Ginseng 7g and Rhizoma Pinelliae 7g.
A kind of Chinese medicine composition for the treatment of esophageal carcinoma of the present invention, described dosage form is decoction or powder.
A kind of preparation method for the treatment of the Chinese medicine composition of esophageal carcinoma of the present invention, with described each crude drug decontamination, earlier Gekko Swinhonis is dried grind into powder standby, again each crude drug was immersed in 450-600 ml water 40-60 minute, decocted 20-25 minute, after the filtrate, medicinal residues add 150-200 milliliter decocting 15 minutes, the filtrate waste is inserted the Gekko Swinhonis powder to stir in the filtrate after twice filtrate merged and is made decoction.
A kind of preparation method for the treatment of the Chinese medicine composition of esophageal carcinoma of the present invention, with described each selection of crude drugs decontamination, clean oven dry, Gekko Swinhonis is dried grind into powder earlier, again other each crude drug is ground into 200-500 order powder, each powder medicine mix homogeneously is made powderous preparations.
The pharmaceutical composition that the present invention selects for use, treating both the principal and secondary aspects of a disease is a purpose to strengthen autoimmunity and to be aided with detoxifcation, the anticancer diffusion makes finally that tumor is dwindled, the unimpeded normal feed of esophagus.
Each crude drug mainly acts on and is in the Chinese medicine composition of the present invention: Herba Solani Lyrati is used for heat-clearing and toxic substances removing; Herba Duchesneae Indicae is used for clearing away heat and cooling blood, subduing swelling and detoxicating; Poria is used for the sharp key of eliminating dampness by diuresis, drying dampness to eliminate phlegm; Pericarpium Citri Reticulatae is used for the intestinal stasis relieving expectorant, the logical the five internal organs of a surname; Flos Inulae is used for expectorant row water preventing or arresting vomiting to be told, and soft painful abdominal mass is hard; Herba Scutellariae Barbatae is used for dispersing swelling and dissipating binds, and dispelling silt hemostasis relieves internal heat; Herba Hedyotidis Diffusae is used for the blood circulation promoting and blood stasis dispelling heat-clearing and toxic substances removing; Rhizoma Smilacis Chinensis is used for dispersing swelling and dissipating binds, heat-clearing and toxic substances removing; Gekko Swinhonis is used to dispel the wind, eliminating stagnation, detoxifcation; Fructus Jujubae is used for replenishing blood and nourishing liver, QI invigorating tonify deficiency, strengthening vital QI to eliminate pathogenic factors, coordinating the actions of various ingredients in a prescription; Rhizoma Zingiberis Recens is used to the cold expelling that induces sweat; The Rhizoma Pinelliae is used for drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass; Arisaema Cum Bile is used for removing heat-phlegm; It is contrary that Haematitum is used for the suppressing the hyperactive liver town, cooling blood for hemostasis; Radix Ginseng is used for the QI invigorating tonification; Bufo siccus is used for detoxifcation, pain relieving.
Above-mentioned each medicine combination is used for hard masses softening and resolving, and clearing heat for detumescence, detoxifcation, strengthening vital QI to eliminate pathogenic factors etc. are purpose with the treating both the principal and secondary aspects of a disease, strengthen body immunity, and cancerous cell is not shifted to other internal organs, tumor is dwindled slowly disappear the unimpeded normal diet of esophagus.
Medicine of the present invention has the curative effect of highly significant to esophageal carcinoma, takes proof through clinical 761 routine patients, and the back produce effects of taking medicine is fast, general 4-10 days begin and can take food, the 725 routine patients obviously stimulating appetite of taking medicine after 1-2 the course of treatment wherein, the transference cure of various influences feeds, 643 routine patients took medicine after 3-4 the course of treatment, antisecosis, weight increase, the mental status return to the preceding situation of disease, and be unimpeded through X-ray and CT examination esophagus, do not find cancer cell metastasis, with asking not recurrence in 1 year.
Medicine of the present invention can only increase its appetite to the uncontrollable cancer cell metastasis of patient of advanced esophageal cancer cancerous cell diffusion.Drug powder of the present invention is taken 3 times every day, each 8 grams, and 20 days is a course of treatment.Medicine decoction of the present invention is one pair of every day, and 20 days is a course of treatment.Period in a medicine is avoided maror.
The specific embodiment
Embodiment
Chinese medicine composition of the present invention can have multiple combination, illustrates to be made up of following multiple Chinese medicinal raw materials in proportion by weight:
1, Herba Solani Lyrati 19g, Herba Duchesneae Indicae 10g, Poria 7g, Pericarpium Citri Reticulatae 10g, Flos Inulae 10g, Herba Scutellariae Barbatae 10g, Herba Hedyotidis Diffusae 20g, Rhizoma Smilacis Chinensis 3g, Gekko Swinhonis 4g, Fructus Jujubae 20g, Rhizoma Zingiberis Recens 20g, Arisaema Cum Bile 10g, Haematitum 10g, Bufo siccus 3g, Radix Ginseng 10g and Rhizoma Pinelliae 10g.
2, Herba Solani Lyrati 16g, Herba Duchesneae Indicae 7g, Poria 6g, Pericarpium Citri Reticulatae 7g, Flos Inulae 7g, Herba Scutellariae Barbatae 7g, Herba Hedyotidis Diffusae 15g, Rhizoma Smilacis Chinensis 2g, Gekko Swinhonis 3g, Fructus Jujubae 15g, Rhizoma Zingiberis Recens 15g, Arisaema Cum Bile 7g, Haematitum 7g, Bufo siccus 2g, Radix Ginseng 7g and Rhizoma Pinelliae 7g.
3, Herba Solani Lyrati 5g, Herba Duchesneae Indicae 5g, Poria 5g, Pericarpium Citri Reticulatae 5g, Flos Inulae 5g, Herba Scutellariae Barbatae 5g, Herba Hedyotidis Diffusae 5g, Rhizoma Smilacis Chinensis 1g, Gekko Swinhonis 3g, Fructus Jujubae 5g, Rhizoma Zingiberis Recens 5g, Arisaema Cum Bile 5g, Haematitum 5g, Bufo siccus 0.5g, Radix Ginseng 5g and Rhizoma Pinelliae 5g.
4, Herba Solani Lyrati 25g, Herba Duchesneae Indicae 15g, Poria 10g, Pericarpium Citri Reticulatae 15g, Flos Inulae 15g, Herba Scutellariae Barbatae 15g, Herba Hedyotidis Diffusae 35g, Rhizoma Smilacis Chinensis 4.5g, Gekko Swinhonis 6g, Fructus Jujubae 35g, Rhizoma Zingiberis Recens 35g, Arisaema Cum Bile 15g, Haematitum 15g, Bufo siccus 5g, Radix Ginseng 15g and Rhizoma Pinelliae 15g.
A kind of preparation method for the treatment of the Chinese medicine composition of esophageal carcinoma of the present invention, with described each crude drug decontamination, earlier Gekko Swinhonis is dried grind into powder standby, again each crude drug was immersed in 450-600 ml water 40-60 minute, decocted 20-25 minute, after the filtrate, medicinal residues add 150-200 milliliter decocting 15 minutes, the filtrate waste is inserted the Gekko Swinhonis powder to stir in the filtrate after twice filtrate merged and is made decoction.
A kind of preparation method for the treatment of the Chinese medicine composition of esophageal carcinoma of the present invention, with described each selection of crude drugs decontamination, clean oven dry, Gekko Swinhonis is dried grind into powder earlier, again other each crude drug is ground into 200-500 order powder, each powder medicine mix homogeneously is made powderous preparations.
Model case:
Case 1, the lijin field, the man, 77 years old now, the peasant was Heze, Shandong Paeonia suffruticosa people.In December, 2006, patient's resistance is choked, and dysphagia is with making digestive tract X ray examination to Heze, Shandong Province municipal hospital, be diagnosed as esophageal carcinoma (hypomere), make a definite diagnosis no radiotherapy chemotherapy in back and operation, back symptom increases the weight of gradually, feed pain occurs, can not take food, vomiting after eating, vomitus is a gastric content, body constitution is become thin gradually.Came me institute to go to a doctor on February 18th, 2008, the patient takes decoction medicine of the present invention, in the time of the 4th day, the black loose stool of suffering from diarrhoea 2 times, feed pain before increases the weight of, be thought of as due to tumor cell comes off, the patient refuses treatment, adheres to continuing to take medicine under the advice its daughter, take medicine 14 days the time, spirit takes a turn for the better, and can take food on a small quantity, and feed pain obviously alleviates, the patient just can normally take food after taking medicine 20 days, feed stops companion's pain relief, and the patient does not have any discomfort symptom after taking medicine 30 days, continues to strengthen treatment and fully recovers after 1 course of treatment.Patient's mental status is good, eats all without hindrance sense of choking of various foods, weight increase, and the X-ray examination esophagus is unobstructed.
Case 2, Qiao Fangming, the man, 74 years old is Heze, Shandong Dingyao County Qiao Zhuan people.In March, 2007, the patient does not have obvious inducement and dysphagia occurs, and foreign body sensation is arranged.The X-ray sheet is diagnosed as esophageal carcinoma in Heze, Shandong city hospital, and pathologic finding is the esophagus scale cancer.Taking the conservative medication symptom does not have alleviation, and increases the weight of gradually, sensation of oppression over the chest with shortness of breath occurs, and cough is coughed up phlegm, and for the sticking expectorant of white foam sample, can not normally take food, and body constitution is become thin gradually.JIUYUE came me institute to go to a doctor on the 29th in 2007, and the patient takes powder of the present invention and suffers from diarrhoea the orange colour loose stool in the time of the 4th day for several times, and Trichiurus haumela squama sample flakelet still can not be taken food, nausea and vomiting, and spirit is poor, the normal reaction that this comes off for tumor.The nausea and vomiting transference cure the 18th day time of taking medicine can be taken food on a small quantity, and spirit takes a turn for the better.Take medicine after the 2nd course of treatment, the patient can normally take food, and stool is normal, and the symptom of breathing hard obviously alleviates, and patient's diet is normal after the course of treatment of continuing to take medicine, antisecosis, and Shandong Province on the 22nd Heze municipal hospital digestive tract X-ray check February in 2008: esophagus is unobstructed.
Claims (4)
1. Chinese medicine composition for the treatment of esophageal carcinoma, it is characterized in that: the raw material of Chinese medicine by the following weight ratio is formed: Herba Solani Lyrati 5-25g, Herba Duchesneae Indicae 5-15g, Poria 5-10g, Pericarpium Citri Reticulatae 5-15g, Flos Inulae 5-15g, Herba Scutellariae Barbatae 5-15g, Herba Hedyotidis Diffusae 5-35g, Rhizoma Smilacis Chinensis 1-4.5g, Gekko Swinhonis 3-6g, Fructus Jujubae 5-35g, Rhizoma Zingiberis Recens 5-35g, Arisaema Cum Bile 5-15g, Haematitum 5-15g, Bufo siccus 0.5-5g, Radix Ginseng 5-15g and Rhizoma Pinelliae 5-15g.
2. a kind of Chinese medicine composition for the treatment of esophageal carcinoma according to claim 1 is characterized in that: the raw material of Chinese medicine by the following weight ratio is formed: Herba Solani Lyrati 25g, Herba Duchesneae Indicae 15g, Poria 10g, Pericarpium Citri Reticulatae 15g, Flos Inulae 15g, Herba Scutellariae Barbatae 15g, Herba Hedyotidis Diffusae 35g, Rhizoma Smilacis Chinensis 4.5g, Gekko Swinhonis 6g, Fructus Jujubae 35g, Rhizoma Zingiberis Recens 35g, Arisaema Cum Bile 15g, Haematitum 15g, Bufo siccus 5g, Radix Ginseng 15g and Rhizoma Pinelliae 15g.
3. a kind of Chinese medicine composition for the treatment of esophageal carcinoma according to claim 1 is characterized in that: the raw material of Chinese medicine by the following weight ratio is formed: Herba Solani Lyrati 19g, Herba Duchesneae Indicae 10g, Poria 7g, Pericarpium Citri Reticulatae 10g, Flos Inulae 10g, Herba Scutellariae Barbatae 10g, Herba Hedyotidis Diffusae 20g, Rhizoma Smilacis Chinensis 3g, Gekko Swinhonis 4g, Fructus Jujubae 20g, Rhizoma Zingiberis Recens 20g, Arisaema Cum Bile 10g, Haematitum 10g, Bufo siccus 3g, Radix Ginseng 10g and Rhizoma Pinelliae 10g.
4. a kind of Chinese medicine composition for the treatment of esophageal carcinoma according to claim 1 is characterized in that: the raw material of Chinese medicine by the following weight ratio is formed: Herba Solani Lyrati 16g, Herba Duchesneae Indicae 7g, Poria 6g, Pericarpium Citri Reticulatae 7g, Flos Inulae 7g, Herba Scutellariae Barbatae 7g, Herba Hedyotidis Diffusae 15g, Rhizoma Smilacis Chinensis 2g, Gekko Swinhonis 3g, Fructus Jujubae 15g, Rhizoma Zingiberis Recens 15g, Arisaema Cum Bile 7g, Haematitum 7g, Bufo siccus 2g, Radix Ginseng 7g and Rhizoma Pinelliae 7g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101388894A CN101342360B (en) | 2008-08-08 | 2008-08-08 | Chinese medicinal composition for treating esophagus cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101388894A CN101342360B (en) | 2008-08-08 | 2008-08-08 | Chinese medicinal composition for treating esophagus cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101342360A CN101342360A (en) | 2009-01-14 |
| CN101342360B true CN101342360B (en) | 2010-12-08 |
Family
ID=40244552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101388894A Expired - Fee Related CN101342360B (en) | 2008-08-08 | 2008-08-08 | Chinese medicinal composition for treating esophagus cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101342360B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109419968A (en) * | 2017-08-21 | 2019-03-05 | 邓泽潭 | A kind of oral traditional Chinese medicine composition for treating the cancer of the esophagus |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102166337A (en) * | 2011-03-31 | 2011-08-31 | 青岛大学 | Ginger and inula flower composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer |
| CN106075195A (en) * | 2016-08-04 | 2016-11-09 | 菏泽海诺知识产权服务有限公司 | A kind of decoction treating esophageal carcinoma |
| CN106334165A (en) * | 2016-11-28 | 2017-01-18 | 广西慧投互联网金融服务有限公司 | Traditional Chinese medicine composition capable of nursing esophagus cancer |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1327807A (en) * | 2000-06-12 | 2001-12-26 | 吴建华 | Chinese medicine for treating neoplasm |
| CN1365784A (en) * | 2001-01-16 | 2002-08-28 | 张同春 | Chinese herbal medicine for treating cancer |
| CN101195022A (en) * | 2007-12-03 | 2008-06-11 | 门连社 | Chinese medicine prescription for curing tumor |
-
2008
- 2008-08-08 CN CN2008101388894A patent/CN101342360B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1327807A (en) * | 2000-06-12 | 2001-12-26 | 吴建华 | Chinese medicine for treating neoplasm |
| CN1365784A (en) * | 2001-01-16 | 2002-08-28 | 张同春 | Chinese herbal medicine for treating cancer |
| CN101195022A (en) * | 2007-12-03 | 2008-06-11 | 门连社 | Chinese medicine prescription for curing tumor |
Non-Patent Citations (1)
| Title |
|---|
| 刘驰.食道癌的食疗便方.《中国食品》.1992,(第5期),9. * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109419968A (en) * | 2017-08-21 | 2019-03-05 | 邓泽潭 | A kind of oral traditional Chinese medicine composition for treating the cancer of the esophagus |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101342360A (en) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100421725C (en) | Chinese medicine composition for treating gastritis and preparing method thereof | |
| CN102940842B (en) | Anti-esophageal cancer drug | |
| CN103041317B (en) | A kind of Chinese medicine composition for the treatment of tumor and preparation method thereof | |
| CN101401925B (en) | Traditional Chinese medicine decoction for treating fatty liver | |
| CN104940784B (en) | A kind of Chinese medicine composition for treating chronic gastritis | |
| CN104258431B (en) | A kind of Chinese medicine composition preparing B ultrasonic contrast agent | |
| CN101342360B (en) | Chinese medicinal composition for treating esophagus cancer | |
| CN103536742B (en) | A kind ofly treat pharmaceutical composition of chronic enterogastritis disease and preparation method thereof | |
| CN100493586C (en) | Oral liquid for treating breast cancer, liver cancer or lung caner, and preparation thereof | |
| CN101670090B (en) | Pharmaceutical composition for treating intermediate and advanced malignant tumors and pharmaceutical uses thereof | |
| CN103330914B (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN104548141A (en) | Digestive tract contrast agent having effect of treating gastrointestinal ulcer and good smearing effect | |
| CN102430105B (en) | Traditional Chinese medicine composite for treating chronic gastritis | |
| CN104721256A (en) | Anwei Yang extract as well as preparation method and medical application thereof | |
| CN104436247A (en) | Contrast agent for detecting gastrointestinal diseases by ultrasonic wave and preparation method thereof | |
| CN104258359A (en) | Traditional Chinese medicine combination for curing pregnancy reaction and preparation method of preparations thereof | |
| CN104383183A (en) | Medicinal composition for treating non-alcoholic fatty liver | |
| CN103316175A (en) | Traditional Chinese medicine powder, and preparation method and application thereof | |
| CN103212012A (en) | Traditional Chinese medicine composition used for treating gastric ulcer | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN110051812A (en) | A kind of strengthening vital QI to eliminate pathogenic factors Chinese medicine and preparation method thereof | |
| CN102579787A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN101693096A (en) | Medicament for treating liver cancer and preparation method thereof | |
| CN101032613B (en) | Hepatic cyst-treating Chinese traditional medicine preparation and its preparation process | |
| CN101352556A (en) | Medicament for treating infertility |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 457000 Yao village, Chengguan Town, Qingfeng County, Henan, Puyang Patentee after: Zhang Tongchun Address before: 252400 west house, building 1, building 2, family building, Shenxian library, Liaocheng, Shandong Patentee before: Zhang Tongchun |
|
| ASS | Succession or assignment of patent right |
Owner name: ZHANG DIANZHI Free format text: FORMER OWNER: ZHANG TONGCHUN Effective date: 20150825 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150825 Address after: 457000 Yao village, Chengguan Town, Qingfeng County, Henan, Puyang Patentee after: Zhang Dianzhi Address before: 457000 Yao village, Chengguan Town, Qingfeng County, Henan, Puyang Patentee before: Zhang Tongchun |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101208 Termination date: 20190808 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |